Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Studies show that there are few if any, additional side effects from the COVID-19 vaccine for people with eczema. In one study, a handful of people who took Dupixent (dupilumab) by injection had an ...

Novartis has axed development of its mid-stage eczema drug ZPL389 ... towards an important FDA approval for its Dupixent (dupilumab) injection for the skin disease also known as atopic dermatitis.

Sanofi’s new atopic dermatitis treatment Dupixent has gained EU approval ... 13 targeting antibody is administered as a subcutaneous injection every other week after an initial loading dose ...

NEW YORK, Nov. 13 (UPI) --Living in places with more air pollution raises the risk of eczema, a chronic condition that causes dry, itchy and inflamed skin, a new study suggests. The study was ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.